Literature DB >> 27404092

Genome Editing in Astyanax mexicanus Using Transcription Activator-like Effector Nucleases (TALENs).

Johanna E Kowalko1, Li Ma2, William R Jeffery3.   

Abstract

Identifying alleles of genes underlying evolutionary change is essential to understanding how and why evolution occurs. Towards this end, much recent work has focused on identifying candidate genes for the evolution of traits in a variety of species. However, until recently it has been challenging to functionally validate interesting candidate genes. Recently developed tools for genetic engineering make it possible to manipulate specific genes in a wide range of organisms. Application of this technology in evolutionarily relevant organisms will allow for unprecedented insight into the role of candidate genes in evolution. Astyanax mexicanus (A. mexicanus) is a species of fish with both surface-dwelling and cave-dwelling forms. Multiple independent lines of cave-dwelling forms have evolved from ancestral surface fish, which are interfertile with one another and with surface fish, allowing elucidation of the genetic basis of cave traits. A. mexicanus has been used for a number of evolutionary studies, including linkage analysis to identify candidate genes responsible for a number of traits. Thus, A. mexicanus is an ideal system for the application of genome editing to test the role of candidate genes. Here we report a method for using transcription activator-like effector nucleases (TALENs) to mutate genes in surface A. mexicanus. Genome editing using TALENs in A. mexicanus has been utilized to generate mutations in pigmentation genes. This technique can also be utilized to evaluate the role of candidate genes for a number of other traits that have evolved in cave forms of A. mexicanus.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27404092      PMCID: PMC4993240          DOI: 10.3791/54113

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  40 in total

1.  Efficient and specific modifications of the Drosophila genome by means of an easy TALEN strategy.

Authors:  Jiyong Liu; Changqing Li; Zhongsheng Yu; Peng Huang; Honggang Wu; Chuanxian Wei; Nannan Zhu; Yan Shen; Yixu Chen; Bo Zhang; Wu-Min Deng; Renjie Jiao
Journal:  J Genet Genomics       Date:  2012-05-08       Impact factor: 4.275

2.  Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs).

Authors:  Yong Lei; Xiaogang Guo; Yun Liu; Yang Cao; Yi Deng; Xiongfeng Chen; Christopher H K Cheng; Igor B Dawid; Yonglong Chen; Hui Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

3.  A mutation in the enzyme monoamine oxidase explains part of the Astyanax cavefish behavioural syndrome.

Authors:  Yannick Elipot; Hélène Hinaux; Jacques Callebert; Jean-Marie Launay; Maryline Blin; Sylvie Rétaux
Journal:  Nat Commun       Date:  2014-04-10       Impact factor: 14.919

4.  Hedgehog signalling controls eye degeneration in blind cavefish.

Authors:  Yoshiyuki Yamamoto; David W Stock; William R Jeffery
Journal:  Nature       Date:  2004-10-14       Impact factor: 49.962

5.  A CRISPR/Cas9 vector system for tissue-specific gene disruption in zebrafish.

Authors:  Julien Ablain; Ellen M Durand; Song Yang; Yi Zhou; Leonard I Zon
Journal:  Dev Cell       Date:  2015-03-05       Impact factor: 12.270

6.  Evolution of an adaptive behavior and its sensory receptors promotes eye regression in blind cavefish.

Authors:  Masato Yoshizawa; Yoshiyuki Yamamoto; Kelly E O'Quin; William R Jeffery
Journal:  BMC Biol       Date:  2012-12-27       Impact factor: 7.431

7.  Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.

Authors:  Tomas Cermak; Erin L Doyle; Michelle Christian; Li Wang; Yong Zhang; Clarice Schmidt; Joshua A Baller; Nikunj V Somia; Adam J Bogdanove; Daniel F Voytas
Journal:  Nucleic Acids Res       Date:  2011-04-14       Impact factor: 16.971

8.  The cavefish genome reveals candidate genes for eye loss.

Authors:  Suzanne E McGaugh; Joshua B Gross; Bronwen Aken; Maryline Blin; Richard Borowsky; Domitille Chalopin; Hélène Hinaux; William R Jeffery; Alex Keene; Li Ma; Patrick Minx; Daniel Murphy; Kelly E O'Quin; Sylvie Rétaux; Nicolas Rohner; Steve M J Searle; Bethany A Stahl; Cliff Tabin; Jean-Nicolas Volff; Masato Yoshizawa; Wesley C Warren
Journal:  Nat Commun       Date:  2014-10-20       Impact factor: 14.919

9.  A potential benefit of albinism in Astyanax cavefish: downregulation of the oca2 gene increases tyrosine and catecholamine levels as an alternative to melanin synthesis.

Authors:  Helena Bilandžija; Li Ma; Amy Parkhurst; William R Jeffery
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

10.  TALENs mediate efficient and heritable mutation of endogenous genes in the marine annelid Platynereis dumerilii.

Authors:  Stephanie Bannister; Olga Antonova; Alessandra Polo; Claudia Lohs; Natalia Hallay; Agne Valinciute; Florian Raible; Kristin Tessmar-Raible
Journal:  Genetics       Date:  2014-03-20       Impact factor: 4.562

View more
  3 in total

Review 1.  Unlocking the Secrets of the Regenerating Fish Heart: Comparing Regenerative Models to Shed Light on Successful Regeneration.

Authors:  Helen G Potts; William T Stockdale; Mathilda T M Mommersteeg
Journal:  J Cardiovasc Dev Dis       Date:  2021-01-16

2.  Repeated evolution of circadian clock dysregulation in cavefish populations.

Authors:  Katya L Mack; James B Jaggard; Jenna L Persons; Emma Y Roback; Courtney N Passow; Bethany A Stanhope; Estephany Ferrufino; Dai Tsuchiya; Sarah E Smith; Brian D Slaughter; Johanna Kowalko; Nicolas Rohner; Alex C Keene; Suzanne E McGaugh
Journal:  PLoS Genet       Date:  2021-07-12       Impact factor: 5.917

3.  Developmental Transcriptomic Analysis of the Cave-Dwelling Crustacean, Asellus aquaticus.

Authors:  Joshua B Gross; Dennis A Sun; Brian M Carlson; Sivan Brodo-Abo; Meredith E Protas
Journal:  Genes (Basel)       Date:  2019-12-29       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.